ECA Logo

In this section: 2015 Course

Course Outline

Swipe right on the table to view more...

2015 Course Outline

Monday,
Sept. 21 2015
Tuesday,
Sept. 22 2015
Wednesday,
Sept. 23 2015
Thursday,
Sept. 24 2015
Friday,
Sept. 25 2015

09:15–09:35

Programme introduction

Professor Frank Nestle,

Nicola Stephens

Professor Reinhard Angelmar  

                        

08:30–12:30

Valuation

Professor Bill Magill

08:30–12:30

Intellectual property – Patent licensing agreements – Clinical trial agreements

Pieter Wyckman

 Olivier Van Obberghen

08:30–12:30
Commercialization options

Professor Paul Kewene-Hite

08:30–10:30
Business plan presentation preparation

Professor Paul Kewene-Hite

09:35–11:15
The biopharmaceutical industry and its environment

Professor Reinhard Angelmar

10:30–12:30
Group presentations

Professor Paul Kewene-Hite

Dr Sara Nunez-Garcia and and panel members

11:30–13:00
The drug development process: from concept to CTA/IND

Dr Brydon Bennett

12:30–13:00
Concluding comments

Professor Reinhard Angelmar

Lunch at INSEAD Restaurant Lunch at INSEAD Restaurant Lunch at INSEAD Restaurant Photo and Lunch at INSEAD Restaurant Packed lunch

14:00–16:30
The drug development process (continued)

Dr Brydon Bennett

14:00–16:15
What entrepreneurs in clinical academia should know about life science funding

Dr Chandra B. Leo

13:30–15:00
Biopharmaceutical companies – academia collaborations

Andrew Hall

13:30–18:00
Essentials of business planning

Professor Paul Kewene-Hite

End of course

16:45–18:00
How I became an academic biotech entrepreneur

 Professor Timothy Radstake

Dr Judit Anido

 

16:30–18:00
Innovation and
Technology Commercialization at the University of Pennsylvania

Dr John S. Swartley 

 

15:15–18:00
Collaboration pharma – academia

Pieter Wyckman

 Olivier Van Obberghen

 

 

 

 

19:00

Opening dinner at Le Cercle

Free evening

19:00

Cocktails at Danièle and Reinhard Angelmar’s home
The academia/
commercial interface

Professor Frank Nestle

19:30

Closing dinner
Lessons of an academic entrepreneur

Professor Carlo Pincelli

 

Tuition fees, on-site accommodation and transport will be covered by FOCIS, thanks to an educational grant by Celgene.